Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.
Klafki HW, Lewczuk P, Kamrowski-Kruck H, Maler JM, Müller K, Peters O, Heuser I, Jessen F, Popp J, Frölich L, Wolf S, Prinz B, Luckhaus C, Schröder J, Pantel J, Gertz HJ, Kölsch H, Müller BW, Esselmann H, Bibl M, Kornhuber J, Wiltfang J.
Klafki HW, et al. Among authors: popp j.
J Alzheimers Dis. 2009;18(3):613-22. doi: 10.3233/JAD-2009-1167.
J Alzheimers Dis. 2009.
PMID: 19625747